SUTENT is used to treat GIST (gastrointestinal stromal tumor). This is a rare cancer of the stomach, bowel, or esophagus. SUTENT is used when the medicine Gleevec® (imatinib mesylate) did not stop the cancer from growing or when you cannot take Gleevec.
Gleevec is a registered trademark of Novartis AG.

If GIST has spread, the doctor may prescribe an anticancer drug. They may slow the
growth of some GIST tumors. Patients who are treated with drugs receive Gleevec
®
(imatinib mesylate) first.
SUTENT
® is used when Gleevec does not stop the cancer from growing or when you cannot
take Gleevec. You can learn more about how SUTENT works in the next section.